About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Insulin Glargine Market Size to Reach 2200 Million by 2031
Insulin Glargine Market
Insulin Glargine Market

Insulin Glargine Market Size, Share & Trends Analysis Report By Type (Lantus, Basaglar, Toujeo, Soliqua/Suliqua, Insulin Glargine Biosimilars) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH55207DR
Last Updated : Nov 03, 2023
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Insulin Glargine Market, By Type (2021-2031)
    1. Lantus
    2. Basaglar
    3. Toujeo
    4. Soliqua/Suliqua
    5. Insulin Glargine Biosimilars
    1. North America
      1. North America Insulin Glargine Market, By Type
        1. Lantus
          1. Basaglar
            1. Toujeo
              1. Soliqua/Suliqua
                1. Insulin Glargine Biosimilars
                2. U.S.
                  1. U.S. Insulin Glargine Market, By Type
                    1. Lantus
                      1. Basaglar
                        1. Toujeo
                          1. Soliqua/Suliqua
                            1. Insulin Glargine Biosimilars
                          2. Canada
                        2. Europe
                          1. Europe Insulin Glargine Market, By Type
                            1. Lantus
                              1. Basaglar
                                1. Toujeo
                                  1. Soliqua/Suliqua
                                    1. Insulin Glargine Biosimilars
                                    2. U.K.
                                      1. U.K. Insulin Glargine Market, By Type
                                        1. Lantus
                                          1. Basaglar
                                            1. Toujeo
                                              1. Soliqua/Suliqua
                                                1. Insulin Glargine Biosimilars
                                              2. Germany
                                              3. France
                                              4. Spain
                                              5. Italy
                                              6. Russia
                                              7. Nordic
                                              8. Benelux
                                              9. Rest of Europe
                                            2. APAC
                                              1. APAC Insulin Glargine Market, By Type
                                                1. Lantus
                                                  1. Basaglar
                                                    1. Toujeo
                                                      1. Soliqua/Suliqua
                                                        1. Insulin Glargine Biosimilars
                                                        2. China
                                                          1. China Insulin Glargine Market, By Type
                                                            1. Lantus
                                                              1. Basaglar
                                                                1. Toujeo
                                                                  1. Soliqua/Suliqua
                                                                    1. Insulin Glargine Biosimilars
                                                                  2. Korea
                                                                  3. Japan
                                                                  4. India
                                                                  5. Australia
                                                                  6. Singapore
                                                                  7. Taiwan
                                                                  8. South East Asia
                                                                  9. Rest of Asia-Pacific
                                                                2. Middle East and Africa
                                                                  1. Middle East and Africa Insulin Glargine Market, By Type
                                                                    1. Lantus
                                                                      1. Basaglar
                                                                        1. Toujeo
                                                                          1. Soliqua/Suliqua
                                                                            1. Insulin Glargine Biosimilars
                                                                            2. UAE
                                                                              1. UAE Insulin Glargine Market, By Type
                                                                                1. Lantus
                                                                                  1. Basaglar
                                                                                    1. Toujeo
                                                                                      1. Soliqua/Suliqua
                                                                                        1. Insulin Glargine Biosimilars
                                                                                      2. Turkey
                                                                                      3. Saudi Arabia
                                                                                      4. South Africa
                                                                                      5. Egypt
                                                                                      6. Nigeria
                                                                                      7. Rest of MEA
                                                                                    2. LATAM
                                                                                      1. LATAM Insulin Glargine Market, By Type
                                                                                        1. Lantus
                                                                                          1. Basaglar
                                                                                            1. Toujeo
                                                                                              1. Soliqua/Suliqua
                                                                                                1. Insulin Glargine Biosimilars
                                                                                                2. Brazil
                                                                                                  1. Brazil Insulin Glargine Market, By Type
                                                                                                    1. Lantus
                                                                                                      1. Basaglar
                                                                                                        1. Toujeo
                                                                                                          1. Soliqua/Suliqua
                                                                                                            1. Insulin Glargine Biosimilars
                                                                                                          2. Mexico
                                                                                                          3. Argentina
                                                                                                          4. Chile
                                                                                                          5. Colombia
                                                                                                          6. Rest of LATAM

                                                                                                      Related Reports

                                                                                                      Global Report
                                                                                                      The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                      Buy Now
                                                                                                      Global Report
                                                                                                      The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                      Buy Now

                                                                                                      Purchase Benefits

                                                                                                      • Eligible for a free updated report next year
                                                                                                      • Completely customizable scope
                                                                                                      • 30% discount on your next purchase
                                                                                                      • Dedicated account manager
                                                                                                      • Query resolution within 24 hours
                                                                                                      • Permission to print the report

                                                                                                      We are featured on :

                                                                                                      www.straitsresearch.com
                                                                                                      © Copyright . All rights Reserved.